PARAMETERS |
CONTROL (n = 45) |
CAD n = (46) |
P |
Age [years] |
45.8 ± 15.0 |
46.1 ± 14.0 |
0.167 |
Gender (M)[%] |
54.7 |
53.3 |
0.894 |
Obesity [%] |
14.6 |
28.3 |
0.125 |
Hypertension [%] |
4.8 |
36.9 |
<0.001 |
Fasting plasma glucose [mg/dl]a |
84.4 ± 6.6 |
95.30 ± 32.1 |
0.034 |
Glycated hemoglobin [%] |
5.5 ± 0.5 |
6.1 ± 1.2 |
0.010 |
Diabetes [%] |
- |
- |
NA |
Serum total cholesterol [mg/dl]a |
174.1 ± 29.6 |
193.0 ± 59.6 |
0.066 |
Serum triglyceride [mg/dl]a |
85.0 ± 36.3 |
113.2 ± 57.1 |
0.008 |
High density Lipoprotein ((HDL) [mg/dl]a |
46.5 ± 8.6 |
45.7 ± 11.7 |
0.741 |
Low density Lipoprotein (LDL) [mg/dl]a |
110.0 ± 27.5 |
124.6 ± 54.1 |
0.136 |
Dyslipidemia[%] |
42.9 |
58.7 |
0.138 |
HOMA-IRa |
1.1 ± 0.6 |
1.7 ± 1.1 |
0.003 |
hs-CRP [mg/L] (geo mean) |
1.28 |
3.24 |
0.029 |
LPS activity (geo mean) |
0.21 |
1.01 |
<0.001 |
Smoking [%] |
35 |
24 |
0.226 |
Metabolic syndrome [%] |
2.4 |
29.5 |
0.001 |
|
aFor FPG, STC, STL, HDL, LDL and HOMA-IR mean ± SD is reported |
Table 1: Clinical characteristics of the study subjects. |